(redirected from Neurofibromatoses)
Also found in: Thesaurus, Medical, Encyclopedia.


 (no͝or′ō-fī′brō-mə-tō′sĭs, nyo͝or′-)
n. Abbr. NF
Any of several genetic diseases characterized by the development of benign tumors of the nerves and, in the most common form, associated with abnormal skin pigmentation and bone deformities.


(Medicine) a condition characterized by the formation of benign tumours on the fibrous coverings of the peripheral nerves and the development of areas of café-au-lait spots


(ˌnʊər oʊ faɪˌbroʊ məˈtoʊ sɪs, ˌnyʊər-)

a genetic disorder characterized by brown patches on the skin, neurofibromas of the skin and internal organs, and in some cases skeletal deformity.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.neurofibromatosis - autosomal dominant disease characterized by numerous neurofibromas and by spots on the skin and often by developmental abnormalities
monogenic disease, monogenic disorder - an inherited disease controlled by a single pair of genes
autosomal dominant disease, autosomal dominant disorder - a disease caused by a dominant mutant gene on an autosome


n neurofibromatosis f
References in periodicals archive ?
The clinical and diagnostic implications of mosaicism in the neurofibromatoses.
Global Markets Direct's, 'Neurofibromatoses - Pipeline Review, H1 2016', provides an overview of the Neurofibromatoses pipeline landscape.
Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes.
USPRwire, Fri Nov 06 2015] GlobalData's clinical trial report, "Neurofibromatoses Global Clinical Trials Review, H2, 2015" provides an overview of Neurofibromatoses clinical trials scenario.
The neurofibromatoses In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ.
Neurofibromatoses - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
The neurofibromatoses are one of the common types of autosomal dominant neurocutaneous disorders which can be divided into neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and 'segmental neurofibromatosis [1], with each types having their own special characteristics and association with other malignancies.
This volume collects recent research and data from clinical studies on the neurofibromatoses, with discussion of the underlying genetics and molecular biology, clinical features, diagnosis and treatment, and need for interdisciplinary medical care.